We are live on ! Find out more
SAM

Simplify Asset Management Portfolio holdings

AUM $7.19B
1-Year Est. Return 6.88%
This Fund
S&P 500
This Quarter Est. Return
+4.37%
1 Year Est. Return
+6.88%
3 Year Est. Return
+44.98%
5 Year Est. Return
+50.08%
10 Year Est. Return
AUM
$697M
AUM Growth
+$48.1M
Cap. Flow
-$52.5M
Cap. Flow %
-7.53%
Top 10 Hldgs %
74.61%
Holding
140
New
62
Increased
24
Reduced
32
Closed
21

Sector Composition

Rank Sector Weight
1 Miscellaneous 86.48%
2 Healthcare 10.82%
3 Energy 1.98%
4 Technology 0.46%
5 Consumer Discretionary 0.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
51
AbbVie
ABBV
$453B
$1.54M 0.22%
9,646
+3,893
+68% +$595K
ZBH icon
52
Zimmer Biomet
ZBH
$18.7B
$1.51M 0.22%
+11,697
New +$1.47M
BDX icon
53
Becton Dickinson
BDX
$50.3B
$1.5M 0.22%
6,065
+2,672
+79% +$654K
IDXX icon
54
Idexx Laboratories
IDXX
$42.2B
$1.47M 0.21%
+2,939
New +$1.41M
UNH icon
55
UnitedHealth
UNH
$356B
$1.26M 0.18%
2,662
-5,335
-67% -$2.57M
NET icon
56
CALL
Cloudflare
NET
$99.3B
$1.22M 0.18%
19,800
-38,000
-66% -$2.08M
ALLO icon
57
Allogene Therapeutics
ALLO
$681M
$1.21M 0.17%
+245,000
New +$1.57M
TCRX icon
58
TScan Therapeutics
TCRX
$26.5M
$1.15M 0.16%
+546,916
New +$1.3M
COO icon
59
Cooper Companies
COO
$13.6B
$1.14M 0.16%
12,164
+5,460
+81% +$469K
DXCM icon
60
DexCom
DXCM
$33.2B
$1.1M 0.16%
9,488
-12,086
-56% -$1.35M
MRNS
61
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1.03M 0.15%
+150,000
New +$941K
STOK icon
62
Stoke Therapeutics
STOK
$1.92B
$1.02M 0.15%
+122,796
New +$1.11M
TMO icon
63
Thermo Fisher Scientific
TMO
$227B
$995K 0.14%
1,727
-520
-23% -$293K
EIGR
64
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$986K 0.14%
+36,655
New +$1.7M
KURA icon
65
Kura Oncology
KURA
$1.18B
$978K 0.14%
+80,000
New +$998K
RVTY icon
66
Revvity
RVTY
$14.5B
$905K 0.13%
+6,788
New +$894K
ABT icon
67
Abbott
ABT
$187B
$850K 0.12%
8,394
-2,500
-23% -$264K
RMD icon
68
ResMed
RMD
$32.9B
$782K 0.11%
3,572
-6,097
-63% -$1.32M
MSFT icon
69
Microsoft
MSFT
$3.71T
$773K 0.11%
+2,680
New +$684K
ELV icon
70
Elevance Health
ELV
$88.4B
$744K 0.11%
1,619
-2,818
-64% -$1.34M
AMED
71
DELISTED
Amedisys
AMED
$705K 0.1%
+9,590
New +$830K
GILD icon
72
Gilead Sciences
GILD
$187B
$700K 0.1%
8,438
+4,176
+98% +$346K
CRWD icon
73
CALL
CrowdStrike
CRWD
$218B
$673K 0.1%
19,600
ESTA icon
74
Establishment Labs
ESTA
$2.21B
$656K 0.09%
9,688
-25,840
-73% -$1.77M
LQD icon
75
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.5B
$622K 0.09%
+5,675
New +$615K

Similar funds

Simplify Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, Simplify Asset Management held 140 positions worth $697M, up 7.4% from $649M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Simplify Asset Management withdrew a net $52.5M in Q1 2023, closing 21 positions and reducing 32 holdings. Its most notable exit was Cigna, an estimated $2.93M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, down from 91% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Simplify Asset Management opened a new position in iShares iBonds Dec 2023 Term Corporate ETF worth $20.2M.

  • Simplify Asset Management's largest Q1 2023 buy was iShares iBonds Dec 2023 Term Corporate ETF: 800,000 shares worth $20.2M.
  • Simplify Asset Management added most to Simplify Aggregate Bond ETF in Q1 2023, an estimated $4.25M increase.
  • Simplify Asset Management's biggest Q1 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $153M.
  • Simplify Asset Management fully exited Cigna in Q1 2023, selling an estimated $2.93M.
  • Simplify Asset Management's ten largest holdings make up 75% of its $697M portfolio in Q1 2023.
  • Simplify Asset Management opened 62 new positions and closed 21 in Q1 2023.
  • Simplify Asset Management's portfolio value rose 7.4% quarter-over-quarter to $697M.

Based on Simplify Asset Management's 13F filing for Q1 2023, filed 10 May 2023.